JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated January 21, 2020 (including amendments thereto) with respect to the shares of Common Stock, $0.001 par value per share, of ArTara Therapeutics, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
DATED: January 21, 2020
By: | /s/ Xxxxx Xxxxxxxxx | |
Xxxxx Xxxxxxxxx | ||
Opaleye, L.P. | ||
By: | /s/ Xxxxx Xxxxxxxxx | |
Name: | Xxxxx Xxxxxxxxx | |
Title: | Managing Member of Opaleye GP LLC, the General Partner of Opaleye, X.X. | |
Xxxxxxx Management Inc. | ||
By: | /s/ Xxxxx Xxxxxxxxx | |
Name: | Xxxxx Xxxxxxxxx | |
Title: | President |